Joseph T. Poterucha1, Saraschandra Vallabhajosyula2, Alexander C. Egbe2, Joseph S. Krien3, Devon O. Aganga4, Kimberly Holst5, Adele W. Golden6, Joseph A. Dearani5, Sheri S. Crow4
Congenital Heart Disease, Vol.14, No.2, pp. 193-200, 2019, DOI:10.1111/chd.12717
Abstract Background: High levels of vasoactive inotrope support (VIS) after congenital heart
surgery are predictive of morbidity in pediatric patients. We sought to discern if this
relationship applies to adults with congenital heart disease (ACHD).
Methods: We retrospectively studied adult patients (≥18 years old) admitted to the
intensive care unit after cardiac surgery for congenital heart disease from 2002 to
2013 at Mayo Clinic. Vasoactive medication dose values within 96 hours of admis‐
sion were examined to determine the relationship between VIS score and poor out‐
come of early mortality, early morbidity, or complication related morbidity.
Results: Overall, 1040… More >
Login
Register
